Skip to main content

Antiviral Technology

Research on the molecular mechanisms of viruses is enabling us to develop new technologies to treat infectious diseases such as influenza.

Antiviral Technology  A new broad-spectrum antiviral
Viruses present an ongoing present and future threat to mankind. Few antiviral drugs or treatments have reached the clinic and virus resistance, as with all microorganisms, is a major problem where antivirals have been deployed. We have discovered how to harness a new generation of naturally-occurring antivirals produced by influenza A virus. One in particular, VH244, is highly active in preclinical tests against many different influenza A viruses, and also against other unrelated respiratory viruses. The next step is human testing in clinical trials.